The authors demonstrate that heterogenous glioblastoma and medulloblastoma cell lines display cytostatic responses to double combinations targeting mitochondrial glycolysis, the phosphatidylinositol 3‐kinase/protein kinase B pathway, or protein phosphatase 2A. This evidence concerns the gene AKT1 and glioblastoma.